"No Meetings with Service Providers: CMO/CRO/Consulting/Lab"
Autotelic Bio is focused on two core areas: RNA therapeutics and small molecule drug development. We are advancing antisense oligonucleotide (ASO) therapies for pancreatic cancer, inflammatory skin conditions, and neurodegenerative diseases, as well as small molecule treatments for chronic diseases.
